SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
SEC Accession No. 0001193125-09-029361
Filing Date
2009-02-13
Accepted
2009-02-13 16:48:39
Documents
7
Effectiveness Date
2009-02-13

Document Format Files

Seq Description Document Type Size
1 POST-EFFECTIVE AMENDMENT NO. 1 ON FORM S-8 TO FORM S-4 ds8pos.htm S-8 POS 53228
2 OPINION OF HOGAN & HARTSON L.L.P. dex51.htm EX-5.1 6640
3 CONSENT OF ERNST & YOUNG LLP dex232.htm EX-23.2 1696
4 CONSENT OF KPMG LLP dex233.htm EX-23.3 1768
5 CONSENT OF KPMG LLP dex234.htm EX-23.4 2117
6 GRAPHIC g28200g64z59.jpg GRAPHIC 3322
7 GRAPHIC g28200g67c08.jpg GRAPHIC 4402
  Complete submission text file 0001193125-09-029361.txt   78000
Mailing Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021
Business Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

IRS No.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 POS | Act: 33 | File No.: 333-154839 | Film No.: 09604627
SIC: 2835 In Vitro & In Vivo Diagnostic Substances